Harris Sliwoski: CBD, Medicare, and the New FDA Enforcement Memo

Harris Sliwoski: CBD, Medicare, and the New FDA Enforcement Memo

We got a new FDA cannabis enforcement memo on Wednesday, April 1, regarding “hemp-derived CBD research in medical research models.” The general thrust is FDA’s assurance that it won’t interfere with a new federal initiative, which covers up to $500 of hemp-derived...